Identifying Risk Factors for Metachronous Colorectal Cancer in Lynch Syndrome
Clinical Gastroenterology and Hepatology · 2026-03 · 24 (3) · 824-834
DOI: 10.1016/j.cgh.2025.06.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-03. Verfasst von Robert Hüneburg und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany; National Center for Hereditary Tumor Syndromes, University Hospital Bonn,…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplasms, Second Primary, Colorectal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Heidelberg, Universitätsklinikum Hamburg-Eppendorf, Medizinischen Hochschule Hannover.
Abstract (Originalsprache)
BACKGROUND & AIMS: Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome. The choice of extended or partial colectomy in patients with LS with primary CRC may influence the risk of metachronous CRC. This study aimed to identify factors associated with metachronous CRC risk and evaluate their potential implications for surgical decision-making. METHODS: We analyzed data from the German Consortium for Familial Intestinal Cancer of patients with LS who underwent either extended or partial colectomy for primary CRC. Cox regression models were used to assess the risk of metachronous CRC, adjusting for sex, age, tumor location, surveillance adherence, and gene. RESULTS: Among 852 LS carriers, 21.1% developed metachronous CRC over a median follow-up of 7.9 years. Among high-risk patients with LS, partial colectomy was associated with a borderline nonsignificant increased risk of metachronous CRC of 3.78 (95% confidence interval, 0.93-15.34; P = .063) compared with extended colectomy. Male sex (hazard ratio [HR], 2.16; P < .001), older age at primary CRC diagnosis (HR, 1.03; P < .001), and left-sided tumor location (HR, 1.53; P = .037) were additional risk factors. Surveillance adherence was not significantly associated with metachronous CRC risk. CONCLUSIONS: This study identifies important risk factors for metachronous CRC in patients with LS, which may support personalized counseling regarding surgical strategies. The findings highlight the complexity of surgical decision-making and the need for individualized approaches. Further studies are required to refine risk stratification and evaluate long-term outcomes to optimize patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany. Electronic address: robert.hueneburg@ukbonn.de.
- Institute for Medical Informatics, Statistics and Epidemiology, Leipzig University, Leipzig, Germany.
- National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany; Institute of Human Genetics, University of Bonn, Bonn, Germany.
- Center of Medical Genetics, Munich, Germany; Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.
- Department of Applied Tumor Biology, Heidelberg University Hospital, Heidelberg, Germany.
- Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
Förderung
- Universitätsklinikum Heidelberg
- Universitätsklinikum Hamburg-Eppendorf
- Medizinischen Hochschule Hannover
- Eberhard Karls Universität Tübingen
- Ludwig-Maximilians-Universität München
Zitieren
APA
Hüneburg, R., Weber, K., Aretz, S., Steinke-Lange, V., Holinski-Feder, E., Kloor, M., Redler, S., Vangala, D. B., Schröck, E., Block, A., Ripperger, T., van Beekum, K., Link, A., Schroeder, C., Engel, C., Nattermann, J., & German Consortium for Familial Intestinal Cancer (2026). Identifying Risk Factors for Metachronous Colorectal Cancer in Lynch Syndrome. Clinical Gastroenterology and Hepatology, 24(3), 824-834. https://doi.org/10.1016/j.cgh.2025.06.040
Vancouver
Hüneburg R, Weber K, Aretz S, Steinke-Lange V, Holinski-Feder E, Kloor M, et al. Identifying Risk Factors for Metachronous Colorectal Cancer in Lynch Syndrome. Clinical Gastroenterology and Hepatology. 2026;24(3):824-834. doi:10.1016/j.cgh.2025.06.040
BibTeX
@article{Hneburg2026,
author = {Hüneburg, Robert and Weber, Karolin and Aretz, Stefan and Steinke-Lange, Verena and Holinski-Feder, Elke and Kloor, Matthias and Redler, Silke and Vangala, Deepak B and Schröck, Evelin and Block, Andreas and Ripperger, Tim and van Beekum, Katrin and Link, Alexander and Schroeder, Christopher and Engel, Christoph and Nattermann, Jacob and German Consortium for Familial Intestinal Cancer, German Consortium for Familial Intestinal Cancer},
title = {Identifying Risk Factors for Metachronous Colorectal Cancer in Lynch Syndrome},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
volume = {24},
number = {3},
pages = {824--834},
doi = {10.1016/j.cgh.2025.06.040}
}
EUVIMED